Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of Sodium Bemiparin for Treatment of Diabetic Foot Ulcers [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of Sodium Bemiparin for the treatment of diabetic foot ulcers has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcers

Drugs mentioned

• Sodium Bemiparin (bemiparin sodium)

Snippet

Sponsor: Rovi Pharmaceuticals Laboratories | Conditions: Foot Ulcer, Diabetic | Phase 3 | Status: COMPLETED